[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.121.230. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1941

SULFANILAMIDE AND ALLIED COMPOUNDS: THEIR VALUE AND LIMITATIONS IN DERMATOLOGY

Author Affiliations

NEW YORK

From the Department of Dermatology, New York University College of Medicine, and the Dermatological Service of the Third (New York University) Medical Division, Bellevue Hospital, service of Dr. Frank C. Combes.

Arch Derm Syphilol. 1941;44(2):236-247. doi:10.1001/archderm.1941.01500020091009
Abstract

The discovery of the potentialities of sulfanilamide and its derivatives has been referred to as "the greatest therapeutic achievement in modern medicine." Not since Ehrlich's epoch-making discovery of arsphenamine has a remedy of such specificity and utility been offered to the world. The literature on the clinical and experimental aspects of this group of drugs is enormous. However, several years must elapse before definite indications, proper dosage and methods of administration are determined.

It is our purpose to state our opinion concerning the value and limitations of sulfanilamide and allied compounds in dermatologic practice, including in addition that of dermatologists from all sections of the United States and of many foreign correspondents.1 Since the literature was reviewed recently by Hughes,2 we have eliminated many references, citing only a few of those not mentioned by this author.

The history of the development of these drugs and the complete study

×